Press Release

Gilead Sciences to Present at Upcoming Investor Conferences

April 26, 2022 at 6:13 PM EDT

FOSTER CITY, Calif.--(BUSINESS WIRE)--Apr. 26, 2022-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

Bank of America Healthcare Conference on Tuesday, May 10 at 5:00pm ET

Bernstein’s Annual Strategic Decisions Conference on Thursday, June 2 at 4:30pm ET

Jefferies Global Healthcare Conference on Wednesday, June 8 at 11:00am ET

Goldman Sachs Global Healthcare Conference on Wednesday, June 15 at 2:20pm ET

The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Jacquie Ross, Investors
Investor_relations@gilead.com

Source: Gilead Sciences, Inc.